Details

Autor(en) / Beteiligte

• Nakajo, Masatoyo
• Kajiya, Yoriko
• Tani, Atsushi
• Jinguji, Megumi
• Nakajo, Masayuki
• Kitazono, Masaki
• Yoshiura, Takashi

Titel

A pilot study for texture analysis of 18F-FDG and 18F-FLT-PET/CT to predict tumor recurrence of patients with colorectal cancer who received surgery

Ist Teil von

• European journal of nuclear medicine and molecular imaging, 2017-12, Vol.44 (13), p.2158-2168

Ort / Verlag

Berlin/Heidelberg: Springer Berlin Heidelberg

Erscheinungsjahr

2017

Quelle

Alma/SFX Local Collection

Beschreibungen/Notizen

• Purpose This retrospective study was done to examine whether the heterogeneity in primary tumor F-18-fluorodeoxyglucose ( 18 F-FDG) and 18 F-3′-fluoro-3′-deoxythymidine ( 18 F-FLT) distribution can predict prognosis of patients with colorectal cancer who received surgery. Methods The enrolled 32 patients with colorectal cancer underwent both 18 F-FDG- and 18 F-FLT-PET/CT studies before surgery. Clinicopathological factors, stage, SUVmax, SUVmean, metabolic tumor volume (SUV ≥ 2.5), total lesion glycolysis, total lesion proliferation and seven texture heterogeneity parameters (coefficient of variation, local parameters: entropy, homogeneity, and dissimilarity; and regional parameters: intensity variability [IV], size-zone variability [SZV], and zone percentage [ZP]) were obtained. Progression free survival (PFS) was calculated by the Kaplan-Meier method. Prognostic significance was assessed by Cox proportional hazards analysis. Results Eight patients had eventually come to progression, and 24 patients were alive without progression during clinical follow-up [mean follow-up PFS; 55.9 months (range, 1-72)]. High stage ( p  = 0.004), high 18 F-FDG-IV ( p  = 0.015), high 18 F-FDG-SZV ( p  = 0.013) and high 18 F-FLT-entropy ( p  = 0.015) were significant in predicting poor 5-year PFS. Other parameters did not predict the disease outcome. At bivariate analysis, disease event hazards ratios for 18 F-FDG-IV and 18 F-FDG-SZV remained significant when adjusted for stage and 18 F-FLT-entropy ( 18 F-FDG-IV; p  = 0.004 [adjusted for stage], 0.007 [adjusted for 18 F-FLT-entropy]; 18 F-FDG-SZV; p  = 0.028 [adjusted for stage], 0.040 [adjusted for 18 F-FLT-entropy]). Conclusion 18 F-FDG PET heterogeneity parameters, IV and SZV, have a potential to be strong prognostic factors to predict PFS of patients with surgically resected colorectal cancer and are more useful than 18 F-FLT-PET/CT heterogeneity parameters.